Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1995 Mar;54(3):159–167. doi: 10.1136/ard.54.3.159

Controversies in lupus: nervous system involvement.

G A Bruyn 1
PMCID: PMC1005546  PMID: 7748011

Abstract

What have we learned about CNS lupus in recent years? An enormous amount of knowledge on pathophysiology of antiphospholipid antibodies, in particular, has been gathered. Although hard evidence of a direct pathogenetic role of these antibodies in cerebral lupus is still lacking, it is generally felt that the multiple microinfarctions found in the brains of lupus patients are related to their presence. Better understanding of the pathogenesis of cerebral lupus will come from the study of experimental models, as it has been possible to develop an antiphospholipid antibody syndrome in mice. Because no specific laboratory test for CNS lupus is yet available, diagnosing the condition remains a challenge to every clinician. Techniques including neuropsychometric testing, quantitative EEG, and SPECT scans have taught us more about cognitive dysfunction and psychosis in patients with SLE. These categories remain the most difficult to define. The concept of hypercoagulability in SLE patients has diverted the direction of therapy from immunosuppression towards anticoagulation. It is of utmost importance that randomised trials are commenced in order to determine the optimal mode of anticoagulation for various groups of lupus patients. It will be necessary to conduct such trials under strict inclusion criteria, based on well defined patient categories. Such an enterprise will require international co-operation of investigators.

Full text

PDF
167

Images in this article

160Image
on p.160
161Image
on p.161

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adam C., Thoua Y., Ronco P., Verroust P., Tovey M., Morel-Maroger L. The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice. Clin Exp Immunol. 1980 May;40(2):373–382. [PMC free article] [PubMed] [Google Scholar]
  2. Alarcón-Segovia D., Delezé M., Oria C. V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., Fernández L., Ponce de León S. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989 Nov;68(6):353–365. doi: 10.1097/00005792-198911000-00003. [DOI] [PubMed] [Google Scholar]
  3. Asherson R. A., Derksen R. H., Harris E. N., Bouma B. N., Gharavi A. E., Kater L., Hughes G. R. Chorea in systemic lupus erythematosus and "lupus-like" disease: association with antiphospholipid antibodies. Semin Arthritis Rheum. 1987 May;16(4):253–259. doi: 10.1016/0049-0172(87)90003-5. [DOI] [PubMed] [Google Scholar]
  4. Asherson R. A., Khamashta M. A., Gil A., Vazquez J. J., Chan O., Baguley E., Hughes G. R. Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome. Am J Med. 1989 Apr;86(4):391–399. doi: 10.1016/0002-9343(89)90335-5. [DOI] [PubMed] [Google Scholar]
  5. Asherson R. A., Mercey D., Phillips G., Sheehan N., Gharavi A. E., Harris E. N., Hughes G. R. Recurrent stroke and multi-infarct dementia in systemic lupus erythematosus: association with antiphospholipid antibodies. Ann Rheum Dis. 1987 Aug;46(8):605–611. doi: 10.1136/ard.46.8.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Atkins C. J., Kondon J. J., Quismorio F. P., Friou G. J. The choroid plexus in systemic lupus erythematosus. Ann Intern Med. 1972 Jan;76(1):65–72. doi: 10.7326/0003-4819-76-1-65. [DOI] [PubMed] [Google Scholar]
  7. Barile L., Lavalle C. Transverse myelitis in systemic lupus erythematosus--the effect of IV pulse methylprednisolone and cyclophosphamide. J Rheumatol. 1992 Mar;19(3):370–372. [PubMed] [Google Scholar]
  8. Bennahum D. A., Messner R. P., Shoop J. D. Brain scan findings in central nervous system involvement by lupus erythematosus. Ann Intern Med. 1974 Dec;81(6):763–765. doi: 10.7326/0003-4819-81-6-763. [DOI] [PubMed] [Google Scholar]
  9. Bilaniuk L. T., Patel S., Zimmerman R. A. Computed tomography of systemic lupus erythematosus. Radiology. 1977 Jul;124(1):119–121. doi: 10.1148/124.1.119. [DOI] [PubMed] [Google Scholar]
  10. Bluestein H. G., Williams G. W., Steinberg A. D. Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med. 1981 Feb;70(2):240–246. doi: 10.1016/0002-9343(81)90756-7. [DOI] [PubMed] [Google Scholar]
  11. Bluestein H. G., Zvaifler N. J. Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus. J Clin Invest. 1976 Feb;57(2):509–516. doi: 10.1172/JCI108303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Boey M. L., Colaco C. B., Gharavi A. E., Elkon K. B., Loizou S., Hughes G. R. Thrombosis in systemic lupus erythematosus: striking association with the presence of circulating lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 8;287(6398):1021–1023. doi: 10.1136/bmj.287.6398.1021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Bonfa E., Golombek S. J., Kaufman L. D., Skelly S., Weissbach H., Brot N., Elkon K. B. Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med. 1987 Jul 30;317(5):265–271. doi: 10.1056/NEJM198707303170503. [DOI] [PubMed] [Google Scholar]
  14. Boumpas D. T., Yamada H., Patronas N. J., Scott D., Klippel J. H., Balow J. E. Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med. 1991 Dec;81(296):975–984. doi: 10.1093/qjmed/81.3.975. [DOI] [PubMed] [Google Scholar]
  15. Boyer R. S., Sun N. C., Verity A., Nies K. M., Louie J. S. Immunoperoxidase staining of the choroid plexus in systemic lupus erythematosus. J Rheumatol. 1980 Sep-Oct;7(5):645–650. [PubMed] [Google Scholar]
  16. Bresnihan B., Oliver M., Grigor R., Hughes G. R. Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement. Clin Exp Immunol. 1977 Dec;30(3):333–337. [PMC free article] [PubMed] [Google Scholar]
  17. Bresnihan B., Oliver M., Williams B., Hughes G. R. An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus. Arthritis Rheum. 1979 Apr;22(4):313–320. doi: 10.1002/art.1780220401. [DOI] [PubMed] [Google Scholar]
  18. Carette S., Urowitz M. B., Grosman H., St Louis E. L. Cranial computerized tomography in systemic lupus erythematosus. J Rheumatol. 1982 Nov-Dec;9(6):855–859. [PubMed] [Google Scholar]
  19. Cathcart E. S., Idelson B. A., Scheinberg M. A., Couser W. G. Beneficial effects of methylprednisolone "pulse" therapy in diffuse proliferative lupus nephritis. Lancet. 1976 Jan 24;1(7952):163–166. doi: 10.1016/s0140-6736(76)91272-1. [DOI] [PubMed] [Google Scholar]
  20. Denburg S. D., Behmann S. A., Carbotte R. M., Denburg J. A. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease. Arthritis Rheum. 1994 Mar;37(3):369–375. doi: 10.1002/art.1780370310. [DOI] [PubMed] [Google Scholar]
  21. Derksen R. H., de Groot P. G., Kater L., Nieuwenhuis H. K. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis. 1993 Sep;52(9):689–692. doi: 10.1136/ard.52.9.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Digre K. B., Durcan F. J., Branch D. W., Jacobson D. M., Varner M. W., Baringer J. R. Amaurosis fugax associated with antiphospholipid antibodies. Ann Neurol. 1989 Mar;25(3):228–232. doi: 10.1002/ana.410250304. [DOI] [PubMed] [Google Scholar]
  23. Ellis S. G., Verity M. A. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. Semin Arthritis Rheum. 1979 Feb;8(3):212–221. doi: 10.1016/s0049-0172(79)80009-8. [DOI] [PubMed] [Google Scholar]
  24. Ellison D., Gatter K., Heryet A., Esiri M. Intramural platelet deposition in cerebral vasculopathy of systemic lupus erythematosus. J Clin Pathol. 1993 Jan;46(1):37–40. doi: 10.1136/jcp.46.1.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Eyanson S., Passo M. H., Aldo-Benson M. A., Benson M. D. Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis. 1980 Aug;39(4):377–380. doi: 10.1136/ard.39.4.377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Futrell N., Millikan C. Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus. Stroke. 1989 May;20(5):583–591. doi: 10.1161/01.str.20.5.583. [DOI] [PubMed] [Google Scholar]
  27. Futrell N., Schultz L. R., Millikan C. Central nervous system disease in patients with systemic lupus erythematosus. Neurology. 1992 Sep;42(9):1649–1657. doi: 10.1212/wnl.42.9.1649. [DOI] [PubMed] [Google Scholar]
  28. Ginsburg K. S., Wright E. A., Larson M. G., Fossel A. H., Albert M., Schur P. H., Liang M. H. A controlled study of the prevalence of cognitive dysfunction in randomly selected patients with systemic lupus erythematosus. Arthritis Rheum. 1992 Jul;35(7):776–782. doi: 10.1002/art.1780350711. [DOI] [PubMed] [Google Scholar]
  29. Golombek S. J., Graus F., Elkon K. B. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus. Arthritis Rheum. 1986 Sep;29(9):1090–1097. doi: 10.1002/art.1780290906. [DOI] [PubMed] [Google Scholar]
  30. Gonzalez-Scarano F., Lisak R. P., Bilaniuk L. T., Zimmerman R. A., Atkins P. C., Zweiman B. Cranial computed tomography in the diagnosis of systemic lupus erythematosus. Ann Neurol. 1979 Feb;5(2):158–165. doi: 10.1002/ana.410050209. [DOI] [PubMed] [Google Scholar]
  31. Gordon C., Emery P. Cytokines and the acute phase response in SLE. Lupus. 1993 Dec;2(6):345–347. doi: 10.1177/096120339300200601. [DOI] [PubMed] [Google Scholar]
  32. Hadler N. M., Gerwin R. D., Frank M. M., Whitaker J. N., Baker M., Decker J. L. The fourth component of complement in the cerebrospinal fluid in systemic Lupus erythematosus. Arthritis Rheum. 1973 Jul-Aug;16(4):507–521. doi: 10.1002/art.1780160411. [DOI] [PubMed] [Google Scholar]
  33. Hanly J. G., Fisk J. D., Sherwood G., Jones E., Jones J. V., Eastwood B. Cognitive impairment in patients with systemic lupus erythematosus. J Rheumatol. 1992 Apr;19(4):562–567. [PubMed] [Google Scholar]
  34. Hanly J. G., Hong C. Antibodies to brain integral membrane proteins in systemic lupus erythematosus. J Immunol Methods. 1993 May 5;161(1):107–118. doi: 10.1016/0022-1759(93)90202-i. [DOI] [PubMed] [Google Scholar]
  35. Hanly J. G., Rajaraman S., Behmann S., Denburg J. A. A novel neuronal antigen identified by sera from patients with systemic lupus erythematosus. Arthritis Rheum. 1988 Dec;31(12):1492–1499. doi: 10.1002/art.1780311205. [DOI] [PubMed] [Google Scholar]
  36. Hanly J. G., Walsh N. M., Fisk J. D., Eastwood B., Hong C., Sherwood G., Jones J. V., Jones E., Elkon K. Cognitive impairment and autoantibodies in systemic lupus erythematosus. Br J Rheumatol. 1993 Apr;32(4):291–296. doi: 10.1093/rheumatology/32.4.291. [DOI] [PubMed] [Google Scholar]
  37. Hanly J. G., Walsh N. M., Sangalang V. Brain pathology in systemic lupus erythematosus. J Rheumatol. 1992 May;19(5):732–741. [PubMed] [Google Scholar]
  38. Hanson V. G., Horowitz M., Rosenbluth D., Spiera H., Puszkin S. Systemic lupus erythematosus patients with central nervous system involvement show autoantibodies to a 50-kD neuronal membrane protein. J Exp Med. 1992 Aug 1;176(2):565–573. doi: 10.1084/jem.176.2.565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Harbeck R. J., Hoffman A. A., Hoffman S. A., Shucard D. W. Cerebrospinal fluid and the choroid plexus during acute immune complex disease. Clin Immunol Immunopathol. 1979 Aug;13(4):413–425. doi: 10.1016/0090-1229(79)90083-7. [DOI] [PubMed] [Google Scholar]
  40. Hay E. M., Black D., Huddy A., Creed F., Tomenson B., Bernstein R. M., Holt P. J. Psychiatric disorder and cognitive impairment in systemic lupus erythematosus. Arthritis Rheum. 1992 Apr;35(4):411–416. doi: 10.1002/art.1780350409. [DOI] [PubMed] [Google Scholar]
  41. Hay E. M., Huddy A., Black D., Mbaya P., Tomenson B., Bernstein R. M., Lennox Holt P. J., Creed F. A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus. Ann Rheum Dis. 1994 May;53(5):298–303. doi: 10.1136/ard.53.5.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Herranz M. T., Rivier G., Khamashta M. A., Blaser K. U., Hughes G. R. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum. 1994 Apr;37(4):568–571. doi: 10.1002/art.1780370418. [DOI] [PubMed] [Google Scholar]
  43. Hiraiwa M., Nonaka C., Abe T., Iio M. Positron emission tomography in systemic lupus erythematosus: relation of cerebral vasculitis to PET findings. AJNR Am J Neuroradiol. 1983 May-Jun;4(3):541–543. [PMC free article] [PubMed] [Google Scholar]
  44. Hirohata S., Miyamoto T. Elevated levels of interleukin-6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement. Arthritis Rheum. 1990 May;33(5):644–649. doi: 10.1002/art.1780330506. [DOI] [PubMed] [Google Scholar]
  45. Hochberg M. C., Boyd R. E., Ahearn J. M., Arnett F. C., Bias W. B., Provost T. T., Stevens M. B. Systemic lupus erythematosus: a review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets. Medicine (Baltimore) 1985 Sep;64(5):285–295. [PubMed] [Google Scholar]
  46. How A., Dent P. B., Liao S. K., Denburg J. A. Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum. 1985 Jul;28(7):789–795. doi: 10.1002/art.1780280710. [DOI] [PubMed] [Google Scholar]
  47. Hughson M. D., McCarty G. A., Sholer C. M., Brumback R. A. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol. 1993 Nov;6(6):644–653. [PubMed] [Google Scholar]
  48. Ishikawa O., Ohnishi K., Miyachi Y., Ishizaka H. Cerebral lesions in systemic lupus erythematosus detected by magnetic resonance imaging. Relationship to anticardiolipin antibody. J Rheumatol. 1994 Jan;21(1):87–90. [PubMed] [Google Scholar]
  49. Johnson R. T., Richardson E. P. The neurological manifestations of systemic lupus erythematosus. Medicine (Baltimore) 1968 Jul;47(4):337–369. doi: 10.1097/00005792-196807000-00002. [DOI] [PubMed] [Google Scholar]
  50. Jongen P. J., Boerbooms A. M., Lamers K. J., Raes B. C., Vierwinden G. Diffuse CNS involvement in systemic lupus erythematosus: intrathecal synthesis of the 4th component of complement. Neurology. 1990 Oct;40(10):1593–1596. doi: 10.1212/wnl.40.10.1593. [DOI] [PubMed] [Google Scholar]
  51. Karpiak S. E., Graf L., Rapport M. M. Antiserum to brain gangliosides produces recurrent epileptiform activity. Science. 1976 Nov 12;194(4266):735–737. doi: 10.1126/science.982041. [DOI] [PubMed] [Google Scholar]
  52. Karpiak S. E., Serokosz M., Rapport M. M. Effects of antisera to S-100 protein and to synaptic membrane fraction on maze performance and EEG. Brain Res. 1976 Feb 6;102(2):313–321. doi: 10.1016/0006-8993(76)90885-4. [DOI] [PubMed] [Google Scholar]
  53. Koren E., Reichlin M. W., Koscec M., Fugate R. D., Reichlin M. Autoantibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells. J Clin Invest. 1992 Apr;89(4):1236–1241. doi: 10.1172/JCI115707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Kushner M. J., Tobin M., Fazekas F., Chawluk J., Jamieson D., Freundlich B., Grenell S., Freemen L., Reivich M. Cerebral blood flow variations in CNS lupus. Neurology. 1990 Jan;40(1):99–102. doi: 10.1212/wnl.40.1.99. [DOI] [PubMed] [Google Scholar]
  55. Lavalle C., Pizarro S., Drenkard C., Sánchez-Guerrero J., Alarcón-Segovia D. Transverse myelitis: a manifestation of systemic lupus erythematosus strongly associated with antiphospholipid antibodies. J Rheumatol. 1990 Jan;17(1):34–37. [PubMed] [Google Scholar]
  56. Lebon P., Lenoir G. R., Fischer A., Lagrue A. Synthesis of intrathecal interferon in systemic lupus erythematosus with neurological complications. Br Med J (Clin Res Ed) 1983 Oct 22;287(6400):1165–1167. doi: 10.1136/bmj.287.6400.1165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Long A. A., Denburg S. D., Carbotte R. M., Singal D. P., Denburg J. A. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus. Ann Rheum Dis. 1990 Apr;49(4):249–253. doi: 10.1136/ard.49.4.249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. McCune W. J., Golbus J., Zeldes W., Bohlke P., Dunne R., Fox D. A. Clinical and immunologic effects of monthly administration of intravenous cyclophosphamide in severe systemic lupus erythematosus. N Engl J Med. 1988 Jun 2;318(22):1423–1431. doi: 10.1056/NEJM198806023182203. [DOI] [PubMed] [Google Scholar]
  59. McCune W. J., MacGuire A., Aisen A., Gebarski S. Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. Arthritis Rheum. 1988 Feb;31(2):159–166. doi: 10.1002/art.1780310202. [DOI] [PubMed] [Google Scholar]
  60. McDonald E. M., Mann A. H., Thomas H. C. Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers. Lancet. 1987 Nov 21;2(8569):1175–1178. doi: 10.1016/s0140-6736(87)91319-5. [DOI] [PubMed] [Google Scholar]
  61. Mevorach D., Raz E., Shalev O., Steiner I., Ben-Chetrit E. Complete heart block and seizures in an adult with systemic lupus erythematosus. A possible pathophysiologic role for anti-SS-A/Ro and anti-SS-B/La autoantibodies. Arthritis Rheum. 1993 Feb;36(2):259–262. doi: 10.1002/art.1780360219. [DOI] [PubMed] [Google Scholar]
  62. Mitsias P., Levine S. R. Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology. 1994 Mar;44(3 Pt 1):385–393. doi: 10.1212/wnl.44.3_part_1.385. [DOI] [PubMed] [Google Scholar]
  63. Molad Y., Sidi Y., Gornish M., Lerner M., Pinkhas J., Weinberger A. Lupus anticoagulant: correlation with magnetic resonance imaging of brain lesions. J Rheumatol. 1992 Apr;19(4):556–561. [PubMed] [Google Scholar]
  64. Nossent J. C., Hovestadt A., Schönfeld D. H., Swaak A. J. Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. Arthritis Rheum. 1991 Nov;34(11):1397–1403. doi: 10.1002/art.1780341109. [DOI] [PubMed] [Google Scholar]
  65. O'CONNOR J. F. Psychoses associated with systemic lupus erythematosus. Ann Intern Med. 1959 Sep;51:526–536. doi: 10.7326/0003-4819-51-3-526. [DOI] [PubMed] [Google Scholar]
  66. Pussell B. A., Blyth F., Charlesworth J. A. Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus. Clin Exp Immunol. 1982 Jan;47(1):133–137. [PMC free article] [PubMed] [Google Scholar]
  67. Ritchlin C. T., Chabot R. J., Alper K., Buyon J., Belmont H. M., Roubey R., Abramson S. B. Quantitative electroencephalography. A new approach to the diagnosis of cerebral dysfunction in systemic lupus erythematosus. Arthritis Rheum. 1992 Nov;35(11):1330–1342. doi: 10.1002/art.1780351114. [DOI] [PubMed] [Google Scholar]
  68. Robbins M. L., Kornguth S. E., Bell C. L., Kalinke T., England D., Turski P., Graziano F. M. Antineurofilament antibody evaluation in neuropsychiatric systemic lupus erythematosus. Combination with anticardiolipin antibody assay and magnetic resonance imaging. Arthritis Rheum. 1988 May;31(5):623–631. doi: 10.1002/art.1780310507. [DOI] [PubMed] [Google Scholar]
  69. Rosove M. H., Brewer P. M. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med. 1992 Aug 15;117(4):303–308. doi: 10.7326/0003-4819-117-4-303. [DOI] [PubMed] [Google Scholar]
  70. Rubbert A., Marienhagen J., Pirner K., Manger B., Grebmeier J., Engelhardt A., Wolf F., Kalden J. R. Single-photon-emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum. 1993 Sep;36(9):1253–1262. doi: 10.1002/art.1780360910. [DOI] [PubMed] [Google Scholar]
  71. Sanders E. A., Hogenhuis L. A. Cerebral vasculitis as presenting symptom of systemic lupus erythematosus. Acta Neurol Scand. 1986 Jul;74(1):75–77. doi: 10.1111/j.1600-0404.1986.tb04630.x. [DOI] [PubMed] [Google Scholar]
  72. Sewell K. L., Livneh A., Aranow C. B., Grayzel A. I. Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus. Am J Med. 1989 May;86(5):625–626. doi: 10.1016/0002-9343(89)90403-8. [DOI] [PubMed] [Google Scholar]
  73. Shiozawa S., Kuroki Y., Kim M., Hirohata S., Ogino T. Interferon-alpha in lupus psychosis. Arthritis Rheum. 1992 Apr;35(4):417–422. doi: 10.1002/art.1780350410. [DOI] [PubMed] [Google Scholar]
  74. Sibbitt W. L., Jr, Sibbitt R. R., Griffey R. H., Eckel C., Bankhurst A. D. Magnetic resonance and computed tomographic imaging in the evaluation of acute neuropsychiatric disease in systemic lupus erythematosus. Ann Rheum Dis. 1989 Dec;48(12):1014–1022. doi: 10.1136/ard.48.12.1014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Sibley J. T., Olszynski W. P., Decoteau W. E., Sundaram M. B. The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol. 1992 Jan;19(1):47–52. [PubMed] [Google Scholar]
  76. Singer J., Denburg J. A. Diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the results of a consensus meeting. The Ad Hoc Neuropsychiatric Lupus Workshop Group. J Rheumatol. 1990 Oct;17(10):1397–1402. [PubMed] [Google Scholar]
  77. Smith H. R., Hansen C. L., Rose R., Canoso R. T. Autoimmune MRL-1 pr/1pr mice are an animal model for the secondary antiphospholipid syndrome. J Rheumatol. 1990 Jul;17(7):911–915. [PubMed] [Google Scholar]
  78. Smith R. W., Ellison D. W., Jenkins E. A., Gallagher P. J., Cawley M. I. Cerebellum and brainstem vasculopathy in systemic lupus erythematosus: two clinico-pathological cases. Ann Rheum Dis. 1994 May;53(5):327–330. doi: 10.1136/ard.53.5.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  79. Stoppe G., Wildhagen K., Seidel J. W., Meyer G. J., Schober O., Heintz P., Künkel H., Deicher H., Hundeshagen H. Positron emission tomography in neuropsychiatric lupus erythematosus. Neurology. 1990 Feb;40(2):304–308. doi: 10.1212/wnl.40.2.304. [DOI] [PubMed] [Google Scholar]
  80. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  81. Teh L. S., Isenberg D. A. Antiribosomal P protein antibodies in systemic lupus erythematosus. A reappraisal. Arthritis Rheum. 1994 Mar;37(3):307–315. doi: 10.1002/art.1780370303. [DOI] [PubMed] [Google Scholar]
  82. Vermess M., Bernstein R. M., Bydder G. M., Steiner R. E., Young I. R., Hughes G. R. Nuclear magnetic resonance (NMR) imaging of the brain in systemic lupus erythematosus. J Comput Assist Tomogr. 1983 Jun;7(3):461–467. doi: 10.1097/00004728-198306000-00015. [DOI] [PubMed] [Google Scholar]
  83. Westerman E. M., Miles J. M., Backonja M., Sundstrom W. R. Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody. Evidence for endothelial injury as the primary event. Arthritis Rheum. 1992 Sep;35(9):1038–1041. doi: 10.1002/art.1780350908. [DOI] [PubMed] [Google Scholar]
  84. Wilson H. A., Winfield J. B., Lahita R. G., Koffler D. Association of IgG anti-brain antibodies with central nervous system dysfunction in systemic lupus erythematosus. Arthritis Rheum. 1979 May;22(5):458–462. doi: 10.1002/art.1780220504. [DOI] [PubMed] [Google Scholar]
  85. Winfield J. B., Brunner C. M., Koffler D. Serologic studies in patients with systemic lupus erythematosus and central nervous system dysfunction. Arthritis Rheum. 1978 Apr;21(3):289–294. doi: 10.1002/art.1780210301. [DOI] [PubMed] [Google Scholar]
  86. van Dam A., Nossent H., de Jong J., Meilof J., ter Borg E. J., Swaak T., Smeenk R. Diagnostic value of antibodies against ribosomal phosphoproteins. A cross sectional and longitudinal study. J Rheumatol. 1991 Jul;18(7):1026–1034. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES